Form S-3 Corbus Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Corbus Pharma (CRBP) Tops Q3 EPS by 2c
November 11, 2015 7:33 AM ESTCorbus Pharma (NASDAQ: CRBP) reported Q3 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
Expected Near-Term Milestones
Continue to screen and enroll patients in both the Phase 2 studies in CF and in systemic sclerosis to remain on track... MoreCorbus Pharma (CRBP) Files $100M Mixed Shelf
November 11, 2015 6:51 AM ESTCorbus Pharma (NASDAQ: CRBP) filed a registration with the U.S. SEC to sell up to $100 million of mixed securities.
... More